Published Aug 4, 2026, 12:48 PM ET · Updated 3 months ago · 2 sources
Novo Nordisk Boosts Forecast on Soaring GLP-1 Sales
bloomberg
·
Original Report
Novo Nordisk A/S raised its forecast for the second time this year, citing higher expectations for its obesity and diabetes drug sales.